The Michigan Technology News Podcast is part of the MediaRica Network
You are currently browsing the archive for the MichBio category.
LANSING - James Greenwood, president and CEO of Bio, the national biotechnology trade group, says Michigan’s traditional strengths - manufacturing and agriculture - could stand the state well in its efforts to develop more biotechnology companies. Greenwood was a keynote speaker in October at MichBio, the state’s life sciences trade association expo at the Lansing Center.
James Greenwood - Michigan's Place In National Biotechnology : Play Now | Play in Popup | Download (355)Interview with Teri Takai, chief information officer for the state of Michigan. Takai talks about the state winning the State Advocacy Award from the Health Information Systems Society for getting named the state that has done the most to promote IT in the healthcare industry.
David Van Andel, chairman of the Van Andel Research Institute, talks about what the Phase II expansion of the center funded by his parents, Jay and Betty Van Andel, means to him personally. He also discusses how the VAI has become the catalyst for a nearly $1 billion construction boom on “Pill Hill” in Grand Rapids. He also urges Michigan’s legislative officials to stop the partisan politics and becomes the leaders the people of the state hoped they would be when they were elected.
Interview with George VandeWoude, director of the Van Andel Research Institute, talks about the Phase II expansion of the cancer R&D facility in downtown Grand Rapids, and how it will create 550 new jobs, pour $170 million into the local economy, and lead to the labs bright future which could one day help eradicate diseases that effect an aging population, including cancer.
Interview with Martyn Coombs, the new CEO of Detroit human tissue bank company Asterand. Coombs, like founder and outgoing CEO Randal Charlton, is from the United Kingdom and has a lot of experience working with the life sciences industries in Europe and Asia.
Interview with Michael Finney, president of Ann Arbor SPARK, who said scores of scientists who soon will be terminated from Pfizer’s Ann Arbor campus have contacted SPARK about getting help starting new life sciences and drug development-related companies based on the work they’ve been doing at Pfizer.
Interview with Michael Finney, president of Ann Arbor SPARK, who talks about what happened at the Jan. 29 emergency meeting of Ann Arbor, Washtenaw County and state business and government leaders that tried to respond to Pfizer announcement that the pharma giant will close its Ann Arbor R&D labs and terminated 2,100 high paying tech jobs.
